Response;Respuesta

Revista Espanola de Cardiologia

Volumn 61, Issue 6, 2008, Pages 654-656

  Artham, Surya M ^a   Ventura, Hector O ^a  

^a OCHSNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN;

CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; HEART FAILURE; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; LETTER; MORTALITY; OBESITY; PROGNOSIS;

EID: 46449087912     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13123076     Document Type: Letter

References (15)

1. Morales-Salinas A. Paradoja de la obesidad o suceptibilidad del bajo peso. Rev Esp Cardiol. 2008;61:653.
2. Artham SM, Ventura HO. Insuficiencia cardiaca y la «paradoja de la obesidad»: la historia continúa. Rev Esp Cardiol. 2007;60:1113-7.
3. Fonarow GC, Srikanthan P, Costanzo MR, ADHERE Scientific Advisory Committee and Investigators. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108.927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J. 2007;153:74-81.
4. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165:55-61.
5. Lavie CJ, Osman AF, Milani RV, Mehra MR. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol. 2003;91:891-4.
6. Horwich TB, Hamilton MA, Maclellan WR, Fonarow GC. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail. 2002;8:216-24.
7. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004; 43:1439-44.
8. Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q, et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med. 2007;120:863-70.
9. Fonarow GC. The relationship between body mass index and mortality in patients hospitalized with acute decompensated heart failure. Am Heart J. 2007;15:e21.
10. Gurm HS, Whitlow PL, Kip KE. The impact of body mass index on short- and long-term outcomes in patients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol. 2002;39:834-40.
11. Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol. 2002;39:578-84.
12. Lavie CJ, Mehra MR, Milani RV. Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J. 2005;26:5-7.
13. Horwich TB, Fonarow GC. Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS. Semin Dial. 2007;20:549-53.
14. Steinberg BA, Cannon CP, Hernandez AF, Pan W, Peterson ED, Fonarow GC. Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database. Am J Cardiol. 2007;100:1331-5.
15. Davos CH, Doehner W, Rauchhaus M, Cicoira M, Francis DP, Coats AJ, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail. 2003;9:29-35.